Influenza Diagnostics Market by Test Type, End-User

List of Tables

The Influenza Diagnostics Market was valued at USD 1.20 billion in 2023, expected to reach USD 1.32 billion in 2024, and is projected to grow at a CAGR of 9.86%, to USD 2.32 billion by 2030.

The influenza diagnostics market involves tools and processes used to identify influenza virus infections. Its necessity stems from the global prevalence of the influenza virus, which causes significant morbidity and mortality annually. Rapid and accurate diagnostics are crucial for patient management, epidemiological surveillance, and the prevention of outbreaks. The application of these diagnostics spans hospitals, clinics, diagnostic laboratories, and research institutions, where they are essential for guiding clinical decisions, managing public health responses, and developing vaccines. Additionally, their end-use includes both human healthcare and veterinary applications, given the zoonotic nature of some influenza strains.

KEY MARKET STATISTICS
Base Year [2023]	USD 1.20 billion
Estimated Year [2024]	USD 1.32 billion
Forecast Year [2030]	USD 2.32 billion
CAGR (%)	9.86%

Key growth factors in the influenza diagnostics market include technological advancements, increased demand for point-of-care testing, and a heightened focus on infectious diseases due to recent pandemics. The aging population and the rising incidence of chronic respiratory diseases further drive demand, positioning the market for robust growth. Opportunities in the market include the development of multiplex diagnostic platforms that can simultaneously test for multiple pathogens, enhancing efficiency and patient outcomes. Companies can capitalize on expanding into emerging markets where healthcare infrastructure improvements are increasing access to diagnostics.

However, market growth may be challenged by the high cost of advanced diagnostics, limited reimbursement in certain regions, and the need for skilled professionals to operate complex diagnostic equipment. Additionally, the rapid mutation of influenza viruses can complicate the development of effective diagnostics. Innovation opportunities lie in the development of faster, more cost-effective, and user-friendly diagnostic solutions, such as those using CRISPR technology or paper-based biosensors. Moreover, integrating artificial intelligence to improve diagnostic accuracy and predict influenza outbreaks offers a promising area for research and business growth. The market is characterized by rapid technological evolution and competitive intensity, necessitating continuous innovation and strategic partnerships to maintain a competitive edge.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Influenza Diagnostics Market

The Influenza Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Prevalence of influenza and increasing number of influenza screening test
- Growth in research funding for influenza diagnostics
- Growing awareness for early detection faster diagnosis using specific diagnostic tests
Market Restraints
- Stringent regulatory framework for the approval of new diagnostic tests
Market Opportunities
- Development of advanced diagnosis test such as CLIA-waived POC molecular influenza tests
- Availability of strong distribution network
Market Challenges
- Rising healthcare costs

Porter's Five Forces: A Strategic Tool for Navigating the Influenza Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Influenza Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Influenza Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Influenza Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Influenza Diagnostics Market

A detailed market share analysis in the Influenza Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Influenza Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Influenza Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Influenza Diagnostics Market

A strategic analysis of the Influenza Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Influenza Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aetna Inc., Becton, Dickinson and Company, Cepheid, Co-Diagnostics, Inc., DIASORIN MOLECULAR LLC, F. Hoffmann-La Roche Ltd., Luminex Corporation, Merck KGaA, Quidel Corporation, SA Scientific Ltd., Sansure Biotech Inc., Secure Diagnostics Pvt. Ltd., Sekisui Diagnostics, LLC, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Influenza Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Test Type, market is studied across Cell Culture, Rapid Influenza Diagnostic Tests, and Reverse Transcription-Polymerase Chain Reaction.
Based on End-User, market is studied across Hospitals, Laboratories, and Point-Of-Care Testing.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-43127F72796F

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Prevalence of influenza and increasing number of influenza screening test
  - 5.1.1.2. Growth in research funding for influenza diagnostics
  - 5.1.1.3. Growing awareness for early detection faster diagnosis using specific diagnostic tests
- 5.1.2. Restraints
  - 5.1.2.1. Stringent regulatory framework for the approval of new diagnostic tests
- 5.1.3. Opportunities
  - 5.1.3.1. Development of advanced diagnosis test such as CLIA-waived POC molecular influenza tests
  - 5.1.3.2. Availability of strong distribution network
- 5.1.4. Challenges
  - 5.1.4.1. Rising healthcare costs
5.2. Market Segmentation Analysis
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Influenza Diagnostics Market, by Test Type

6.1. Introduction
6.2. Cell Culture
6.3. Rapid Influenza Diagnostic Tests
6.4. Reverse Transcription-Polymerase Chain Reaction

7. Influenza Diagnostics Market, by End-User

7.1. Introduction
7.2. Hospitals
7.3. Laboratories
7.4. Point-Of-Care Testing

8. Americas Influenza Diagnostics Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Influenza Diagnostics Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Influenza Diagnostics Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.4. Strategy Analysis & Recommendation

Companies Mentioned

1. Abbott Laboratories
2. Aetna Inc.
3. Becton, Dickinson and Company
4. Cepheid
5. Co-Diagnostics, Inc.
6. DIASORIN MOLECULAR LLC
7. F. Hoffmann-La Roche Ltd.
8. Luminex Corporation
9. Merck KGaA
10. Quidel Corporation
11. SA Scientific Ltd.
12. Sansure Biotech Inc.
13. Secure Diagnostics Pvt. Ltd.
14. Sekisui Diagnostics, LLC
15. Thermo Fisher Scientific Inc.